Posttransplant cutaneous T-cell lymphoma: Case reports and review of the association of calcineurin inhibitor use with posttransplant lymphoproliferative disease risk

Archives of Dermatology

Volumn 146, Issue 5, 2010, Pages 513-516

  Pomerantz, Rebecca G ^a   Campbell, Lauren S ^a   Jukic, Drazen M ^a   Geskin, Larisa J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEXAROTENE; CHLORMETHINE; CYCLOSPORIN; DENILEUKIN DIFTITOX; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; AGED; ALOPECIA; ARTICLE; CANCER RELAPSE; CASE REPORT; CUTANEOUS T CELL LYMPHOMA; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ECTROPION; ERYTHEMA; ERYTHRODERMA; HUMAN; HUMAN TISSUE; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; MYCOSIS FUNGOIDES; NEPHRITIS; PALMOPLANTAR KERATODERMA; PRIORITY JOURNAL; PUVA; RASH; RECOMMENDED DRUG DOSE; SEZARY CELL; SEZARY SYNDROME; SKIN PRURITUS; TREATMENT RESPONSE; WEGENER GRANULOMATOSIS;

ADULT; AGED; CALCINEURIN; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOMA, T-CELL, CUTANEOUS; MALE; RISK FACTORS; SEX FACTORS; SKIN NEOPLASMS; TACROLIMUS;

EID: 77952628621     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.60     Document Type: Article

References (38)

1. Ravat FE, Spittle MF, Russell-Jones R. Primary cutaneous T-cell lymphoma occurring after organ transplantation. J Am Acad Dermatol. 2006;54(4):668-675.
2. Velankar MM, Kini AR. Ocular involvement by T-cell post-transplant lymphoproliferative disorder of cutaneous origin. Pathology. 2007;39(3):369-371. (Pubitemid 46897589)
3. Laffitte E, Venetz JP, Aubert JD, Duchosal MA, Panizzon RG, Pascual M. Mycosis fungoides in a lung transplant recipient with advanced ciclosporin nephropathy: management with mechlorethamine and subsequent renal transplantation. Dermatology. 2008;217(1):87-88. (Pubitemid 351896579)
4. Rodríguez-Gil Y, Palencia SI, Lopez-Rios F, Ortiz PL, Rodriguez-Peralto JL. Mycosis fungoides after solid-organ transplantation: report of 2 new cases. Am J Dermatopathol. 2008;30(2):150-155. (Pubitemid 351441988)
5. Gottschalk S, Rooney CM, Heslop HE. Post-transplant lymphoproliferative disorders. Annu Rev Med. 2005;56:29-44.
6. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Simmons RL. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation. 1985;39(5): 461-472. (Pubitemid 15036441)
7. Liebowitz D. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. N Engl J Med. 1998;338(20):1413-1421. (Pubitemid 28221982)
8. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl. 1998:147-158.
9. Morrison VA, Dunn DL, Manivel JC, Gajl-Peczalska KJ, Peterson BA. Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med. 1994; 97(1):14-24.
10. Nalesnik MA. Clinicopathologic characteristics of post-transplant lymphoproliferative disorders. Recent Results Cancer Res. 2002;159:9-18.
11. Penn I. Cancers following cyclosporine therapy. Transplantation. 1987;43(1):32-35.
12. Boubenider S, Hiesse C, Goupy C, Kriaa F, Marchand S, Charpentier B. Incidence and consequences of post-transplantation lymphoproliferative disorders. J Nephrol. 1997;10(3):136-145. (Pubitemid 27297130)
13. Swerdlow SH. Post-transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease. Histopathology. 1992;20(5):373-385.
14. Penn I. Cancers in cyclosporine-treated vs azathioprine-treated patients. Transplant Proc. 1996;28(2):876-878.
15. Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet. 1993;342(8886-8887):1514-1516. (Pubitemid 23362168)
16. Opelz G, Döhler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant. 2004;4(2):222-230. (Pubitemid 38248525)
17. Cox KL, Lawrence-Miyasaki LS, Garcia-Kennedy R, et al. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation. 1995;59(4):524-529.
18. Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation. 2005;80(9):1233-1243. (Pubitemid 41746802)
19. Haddad EM, McAlister VC, Renouf E, Malthaner R, Kjaer MS, Gluud LL. Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst Rev. 2006;(4):CD005161.
20. Kiguchi K, Collart FR, Henning-Chubb C, Huberman E. Induction of cell differentiation in melanoma cells by inhibitors of IMP dehydrogenase: altered patterns of IMP dehydrogenase expression and activity. Cell Growth Differ. 1990; 1(6):259-270.
21. Floryk D, Tollaksen SL, Giometti CS, Huberman E. Differentiation of human prostate cancer PC-3 cells induced by inhibitors of inosine 5′-monophosphate dehydrogenase. Cancer Res. 2004;64(24):9049-9056.
22. Tressler RJ, Garvin LJ, Slate DL. Anti-tumor activity of mycophenolate mofetil against human and mouse tumors in vivo. Int J Cancer. 1994;57(4):568-573. (Pubitemid 2076858)
23. Takebe N, Cheng X, Fandy TE, et al. IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cells. Mol Cancer Ther. 2006;5(2):457-466.
24. Huang Y, Liu Z, Huang H, Liu H, Li L. Effects of mycophenolic acid on endothelial cells. Int Immunopharmacol. 2005;5(6):1029-1039. (Pubitemid 40501747)
25. Laliberté J, Yee A, Xiong Y, Mitchell BS. Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes. Blood. 1998;91(8):2896-2904. (Pubitemid 28227540)
26. Penn I, Brunson ME. Cancers after cyclosporine therapy. Transplant Proc. 1988; 20(3)(suppl 3):885-892.
27. Penn I. Cancers complicating organ transplantation. N Engl J Med. 1990;323(25): 1767-1769.
28. McGregor JM, Yu CC, Lu QL, Cotter FE, Levison DA, MacDonald DM. Posttransplant cutaneous lymphoma. J Am Acad Dermatol. 1993;29(4):549-554.
29. Lippman SM, Grogan TM, Carry P, Ogden DA, Miller TP. Post-transplantation T cell lymphoblastic lymphoma. Am J Med. 1987;82(4):814-816.
30. Ulrich W, Chott A, Watschinger B, Reiter C, Kovarik J, Radaszkiewicz T. Primary peripheral T cell lymphoma in a kidney transplant under immunosuppression with cyclosporine A. Hum Pathol. 1989;20(10):1027-1030. (Pubitemid 19267911)
31. Hanson MN, Morrison VA, Peterson BA, et al. Posttransplant T-cell lymphoproliferative disorders: an aggressive, late complication of solid-organ transplantation. Blood. 1996;88(9):3626-3633.
32. Zutter MM, Martin PJ, Sale GE, et al. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood. 1988;72(2):520-529.
33. Leblond V, Sutton L, Dorent R, et al. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. J Clin Oncol. 1995;13(4):961-968.
34. Kemnitz J, Cremer J, Gebel M, Uysal A, Haverich A, Georgii A. T-cell lymphoma after heart transplantation. Am J Clin Pathol. 1990;94(1):95-101.
35. Väkevä L, Pukkala E, Ranki A. Increased risk of secondary cancers in patients with primary cutaneous T cell lymphoma. J Invest Dermatol. 2000;115(1):62-65.
36. Kantor AF, Curtis RE, Vonderheid EC, van Scott EJ, Fraumeni JF Jr. Risk of second malignancy after cutaneous T-cell lymphoma. Cancer. 1989;63(8):1612-1615. (Pubitemid 19093291)
37. U.S. Department of Health and Human Services. Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1996-2005. Rockville, MD: Division of Transplantation, Healthcare Systems Bureau, Health Resources and Services Administration; 2006.
38. Criscione VD, Weinstock MA. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol. 2007;143(7):854-859.